GT Metabolic™ Solutions Introduces Expanded MagDI™ System with New FDA-Cleared 50mm Magnet

GT Metabolic™ Solutions Expands MagDI™ System

GT Metabolic™ Solutions, Inc., a pioneer in magnetic surgery, has exciting news to share. The company recently announced that the U.S. Food and Drug Administration (FDA) approved a new, larger 50mm magnet for its MagDI™ System. This addition complements the existing 40mm magnet, thus broadening the operational capabilities for surgeons using this technology in magnet-assisted surgical procedures, specifically for duodenal-ileal anastomosis.

With this expansion, surgeons can now cater to a wider array of patient conditions, enhancing the overall effectiveness and adaptability of the procedures. The MagDI™ System is recognized for revolutionizing surgery by offering a technology that is self-aligning, incisionless, sutureless, and staple-free, ultimately leaving no foreign material behind that could otherwise interfere with the healing process.

The introduction of the 50mm magnet is designed to provide greater flexibility for surgeons, enabling them to customize their surgical approach based on individual patient needs. This innovative system allows for a seamless integration of sizes during surgery, facilitating a smooth, non-invasive approach that promotes better patient outcomes. Dr. Phil Gachassin, Medical Director of Metabolic and Bariatric Surgery at Ochsner Lafayette General Medical Center, expressed his satisfaction with the early results of the MagDI™ System, emphasizing the promising outcomes observed in patients undergoing the magnetic compression anastomosis technique.

The inclusion of the 50mm magnet strengthens the existing capabilities of the MagDI™ System. This system possesses the unique distinction of being the only FDA-cleared and commercially available magnetic compression anastomosis product. GT Metabolic Solutions is committed to pushing the boundaries in minimally invasive surgical techniques, aiming to provide medical professionals with advanced tools that enhance procedural efficiency while improving patient recovery times.

Thierry Thaure, the CEO and co-founder of GT Metabolic Solutions, stated, “This expansion reinforces our commitment to advancing minimally invasive, magnetic surgery. We aim to provide surgeons with enhanced tools that can positively impact patient outcomes.” Alongside him, co-founder Dr. Michel Gagner shared insights on the importance of the system's clinical success, highlighting the new 50mm option’s role in extending the reach and impact of the MagDI™ System in the field of bariatric surgery.

Given the growing demand for surgical techniques that are less invasive yet highly efficient, GT Metabolic Solutions is dedicated to expediting the U.S. market introduction of the MagDI™ System. Ongoing clinical evidence continues to validate the effectiveness of this approach, illustrating a lack of reported complications such as leaks or bleeds from utilizing this innovative technique.

Ronald Galovich, Vice President of Sales and Marketing at GT Metabolic, remarked, “The increasing interest in the MagDI™ System underscores its potential for transforming bariatric surgery. It presents enhanced procedural efficiency for surgeons while significantly benefiting patients.”

GT Metabolic Solutions Inc. remains at the forefront of developing magnetic compression anastomosis technologies, positioning itself as a leader in minimally invasive surgical techniques globally. The company is uniquely focused on improving outcomes for patients undergoing bariatric and metabolic surgeries and is committed to revolutionizing the surgical landscape through its advanced solutions.

As the healthcare industry continues to evolve with a focus on patient-centric innovations, the expansion of the MagDI™ System stands to play a key role in shaping the future of magnetic surgery. This initiative reflects GT Metabolic's dedication to continuous improvement and innovation in surgical procedures and improving overall health outcomes.